[Federal Register Volume 80, Number 87 (Wednesday, May 6, 2015)]
[Notices]
[Pages 26051-26053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-10543]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-15-0978; Docket No. CDC-2015-0030]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the proposed 
information collection for the Emerging Infections Program. The 
Emerging Infections Programs (EIPs) are population-based centers of 
excellence established through a network of state health departments 
collaborating with academic institutions; local health departments; 
public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases through population-based surveillance.

DATES: Written comments must be received on or before July 6, 2015.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0030 by any of the following methods:
     Federal eRulemaking Portal: Regulation.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including

[[Page 26052]]

whether the information shall have practical utility; (b) the accuracy 
of the agency's estimate of the burden of the proposed collection of 
information; (c) ways to enhance the quality, utility, and clarity of 
the information to be collected; (d) ways to minimize the burden of the 
collection of information on respondents, including through the use of 
automated collection techniques or other forms of information 
technology; and (e) estimates of capital or start-up costs and costs of 
operation, maintenance, and purchase of services to provide 
information. Burden means the total time, effort, or financial 
resources expended by persons to generate, maintain, retain, disclose 
or provide information to or for a Federal agency. This includes the 
time needed to review instructions; to develop, acquire, install and 
utilize technology and systems for the purpose of collecting, 
validating and verifying information, processing and maintaining 
information, and disclosing and providing information; to train 
personnel and to be able to respond to a collection of information, to 
search data sources, to complete and review the collection of 
information; and to transmit or otherwise disclose the information.

Proposed Project

    Emerging Infections Program--(OMB Control No. 0920-0978, Expires 8/
31/2016)--Revision--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based 
centers of excellence established through a network of state health 
departments collaborating with academic institutions; local health 
departments; public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases. Various parts of the EIP have received 
separate Office of Management and Budget (OMB) clearances (Active 
Bacterial Core Surveillance [ABCs]--OMB number 0920-0802 and All Age 
Influenza Hospitalization Surveillance--OMB number 0920-0852); however 
this request seeks to have all core EIP activities under one clearance.
    Activities of the EIPs fall into the following general categories: 
(1) Active surveillance; (2) applied public health epidemiologic and 
laboratory activities; (3) implementation and evaluation of pilot 
prevention/intervention projects; and (4) flexible response to public 
health emergencies.
    Activities of the EIPs are designed to: (1) Address issues that the 
EIP network is particularly suited to investigate; (2) maintain 
sufficient flexibility for emergency response and new problems as they 
arise; (3) develop and evaluate public health interventions to inform 
public health policy and treatment guidelines; (4) incorporate training 
as a key function; and (5) prioritize projects that lead directly to 
the prevention of disease.
    Proposed respondents will include state health departments who may 
collaborate with one or more of the following: Academic institutions, 
local health departments, public health and clinical laboratories, 
infection control professionals, and healthcare providers. Frequency of 
reporting will be determined as cases arise.
    The total estimated burden is 22,755 hours. There is no cost to 
respondents other than their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
               Type of respondent                               Form name                    Number of     responses per   per response    Total burden
                                                                                            respondents     respondent      (in hours)      (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department........................  ABCs Case Report Form..................              10             809           20/60           2,697
                                                 Invasive Methicillin-resistant                       10             609           20/60           2,030
                                                  Staphylococcus aureus ABCs Case Report
                                                  Form.
                                                 ABCs Invasive Pneumococcal Disease in                10              22           10/60              37
                                                  Children Case Report Form.
                                                 ABCs Non-Bacteremic Pneumococcal                     10             100           10/60             167
                                                  Disease Case Report Form.
                                                 Neonatal Infection Expanded Tracking                 10              37           20/60             123
                                                  Form.
                                                 ABCs Legionellosis Case Report Form....              10             100           20/60             333
                                                 Campylobacter..........................              10             637           20/60           2,123
                                                 Cryptosporidium........................              10             130           10/60             217
                                                 Cyclospora.............................              10               3           10/60               5
                                                 Listeria monocytogenes.................              10              13           20/60              43
                                                 Salmonella.............................              10             827           20/60           2,757
                                                 Shiga toxin producing E. coli..........              10              90           20/60             300
                                                 Shigella...............................              10             178           10/60             297
                                                 Vibrio.................................              10              20           10/60              33
                                                 Yersinia...............................              10              16           10/60              27
                                                 Hemolytic Uremic Syndrome..............              10              10               1             100
                                                 Influenza Hospitalization Surveillance               10             400           15/60           1,000
                                                  Project Case Report Form.
                                                 Influenza Hospitalization Surveillance               10             100            5/60              83
                                                  Project Vaccination Telephone Survey.
                                                 Influenza Hospitalization Surveillance               10             100            5/60             83v
                                                  Project Vaccination Telephone Survey
                                                  Consent Form.
EIP site.......................................  CDI Case Report Form...................              10           1,650           20/60           5,500
                                                 CDI Treatment Form.....................              10           1,650           10/60           2,750
                                                 Resistant Gram-Negative Bacilli Case                 10             500           20/60           1,667
                                                  Report Form.
Person in the community infected with C.         Screening Form.........................             600               1            5/60              50
 difficile (CDI Cases).

[[Page 26053]]

 
                                                 Telephone interview....................             500               1           40/60             333
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............          22,728
--------------------------------------------------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-10543 Filed 5-5-15; 8:45 am]
BILLING CODE 4163-18-P